Volume 3, Issue 1, January 2018, Page: 1-5
Prevalence of Hepatitis B Virus Infection Among Patients with Chronic Kidney Disease in Jos University Teaching Hospital (JUTH) Jos, Nigeria
Jude Yunzoom Nkup, Department of Microbiology, Faculty of Natural Sciences, University of Jos, Jos, Nigeria
Prisca Ofoeke, Department of Microbiology, Faculty of Natural Sciences, University of Jos, Jos, Nigeria
Julius Ocheme Okojokwu, Department of Microbiology, Faculty of Natural Sciences, University of Jos, Jos, Nigeria
Otobo Innocent Ujah, Department of Obstetrics and Gynecology, Jos University Teaching Hospital, Jos, Nigeria
Emeka Ubah Ejeliogu, AIDS Prevention Initiative in Nigeria, Jos University Teaching Hospital, Jos, Nigeria; Department of Pediatric, University of Jos, Jos, Nigeria
Joseph Aje Anejo-Okopi, Department of Microbiology, Faculty of Natural Sciences, University of Jos, Jos, Nigeria; AIDS Prevention Initiative in Nigeria, Jos University Teaching Hospital, Jos, Nigeria
Received: Sep. 23, 2017;       Accepted: Oct. 16, 2017;       Published: Dec. 5, 2017
DOI: 10.11648/j.ajlm.20180301.11      View  1117      Downloads  74
Abstract
The frequency of hepatitis B virus in patients with CKD undergoing haemodialysis maintenance has a medical importance in the transmission of the infection and the cause of kidney disease. We aimed to determine sero-prevalence of HBV in patients with chronic kidney disease. A total of 110 blood samples were collected from nephrology Department of Jos University Teaching Hospital and screened for HBsAg marker. HBsAg was detected using rapid chromatographic immunoassays for qualitative detection of HBsAg and was performed using one-step test strips for detection of HBsAg in serum sample. Out of the 110 patients selected, 56 were males and 54 females with an overall 15.5% HBsAg positivity. It was observed that HBsAg positive increases with prolonged duration of haemodialysis maintenance. The prevalence of HBsAg among Chronic Kidney Disease patients is high, however there was no significant association between HBV and chronic kidney disease in this cross-Sectional survey.
Keywords
HBV, Infection, Chronic Kidney Disease, JUTH
To cite this article
Jude Yunzoom Nkup, Prisca Ofoeke, Julius Ocheme Okojokwu, Otobo Innocent Ujah, Emeka Ubah Ejeliogu, Joseph Aje Anejo-Okopi, Prevalence of Hepatitis B Virus Infection Among Patients with Chronic Kidney Disease in Jos University Teaching Hospital (JUTH) Jos, Nigeria, American Journal of Laboratory Medicine. Vol. 3, No. 1, 2018, pp. 1-5. doi: 10.11648/j.ajlm.20180301.11
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
M. J. Alter, and E. E. Mast. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am; (23): 437–455, 1994.
[2]
U. Petr. Viral Hepatitis Infections in Chronic Kidney Disease Patients and Renal Transplant Recipients. Kidney Blood Press Research; (35): 454–467, 2012.
[3]
A. E. Otedo, S. O. MC Ligeyo, F. A. Okoth, and J. K. Kayima. Seroprevalence of hepatitis B and hepatitis C in maintenance dialysis in a public hospital in a developing country. South African Medical Journal; 93: 380-4, 2003.
[4]
L. Finelli, J. T. Miller, J. I. Tokars, M. J. Alter, and M. J. Arduino. National surveillance of dialysis associated diseases in the United States. Semin Dial; (18): 52–61, 2005.
[5]
L. A. Kondili, D. Genovese, C. Argentini, P. Chionne, P. Toscani, R. Fabro, R. Cocconi, and M. Rapicetta. Nosocomial transmission in simultaneous outbreaks of hepatitis C and B virus infections in a haemodialysis center. European Journal of Clinical Microbiology and Infectious Diseases; (25): 527–531, 2006.
[6]
Center for Disease Prevention and Control (CDC). Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep; 50 (RR-5): 1-43, 2001.
[7]
S. A. Teles, R. M. B. Martins, C. L. R. Lopes, M. A. Carneiro, K. P. Souza, and C. F. T. Yoshida. Immunogenicity of a recombinant hepatitis B vaccine (Euvax-B) in a hemodialysis patients and staff. Europian Journal of Epidemiology; (17): 145-49, 2001.
[8]
S. U. Busek, E. H. Baba, E. Tavares, H. A. Filho, L. Pimenta, A. Salomao, R. Correa Oliveira, and G. C. Oliveira. Hepatitis C and hepatitis B virus infection in different hemodialysis units in Belo Horizonte, Minas Gerais, Brazil. Mem Inst Oswaldo Cruz; (97): 775-778, 2002.
[9]
M. Devesa, Y. E. Khudyakov, F. Capriles, L. Blitz, H. A. Fields, F. Liprandi, and F. H. Pujol. Reduced Antibody Reactivity to Hepatitis C Virus Antigens Hemodialysis Patients Coinfected with Hepatitis B Virus. Clinical and Diagnostic Laboratory Immunology; (4): 639-642, 1997.
[10]
N. K. C. Tong, J. Beran, S. A. Kee, J. L. Miguel, C. Sanchez, J. M. Bayas, A. Vilella, J. R. De Juanes, P. Arrazola, F. C. Torrecillas, E. L. De Novales, V. Hamtiaux, M. Lievens, and M. Stoffel. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-dialysis and hemodialysis patients. Kidney Int; (68): 2298-2303, 2005.
[11]
S. Chattopadhyay, S. Rao, B. C. Das, N. P. Singh, and P. Kar. Prevalence of transmitted virus infection in patients on maintenance hemodialysis from New Delhi, India. Hemodial Int; (9): 362-6, 2005.
[12]
D. Sit, A. K. Kadiroglu, H. Kayabasi, M. E. Yilmaz, and V. Goral. Seroprevalence of hepatitis B and C viruses in patients with chronic kidney disease in the predialysis stage at a university hospital in Turkey; (50): 133-7, 2007.
[13]
W. A. Alashek, C. W. Meintyre, and M. W. Taal. Hepatitis B and C infection in hemodialysis patients in Libya: prevalence incidence and risk factors. BMC Infect Dis 12: 265, 2012.
[14]
J. K. Unger, and H. Peters. Hepatitis B in chronic kidney disease: Moving toward effective prevention. Kidney Int; (73): 799‑801, 2008.
[15]
R. Bhimma, H. M. Coovadia, and M. Adhilari. Hepatitis B virus‑associated nephropathy membranous nephropathy in black South African children. Pediatr Nephrol; (11): 429‑34, 1998.
[16]
A. Akinsola, O. Olusanya, A. O. Iyun, and, C. O. Mbanefo. Role of hepatitis Bs antigen in chronic glomerulonephritides in Nigerians. Afr J Med Med Sci; 13: 33‑9, 1984.
[17]
D. N. Bukbuka, A, P. Barsi, and Z. M. Mungoro. Seroprevalence of hepatitis B surface antigen among primary school pupils in rural Hawal Valley, Borno State, Nigeria. Nigeria. Journal of Community Medicine and Primary Health Care; 17 (1): 20-23, 2005.
[18]
E. Marirnier, V. Barrois, B. Larouze, W. T. London, A. Cofer, L. Diakhate, and B. S. Blumberg. Lack of perinatal transmission of hepatitis B virus infection in Senegal, West Africa. Journal of Paediatrics; 106 (5): 843-849, 1985.
[19]
K. Anwar, M. Imran, F. Shahzad, M. Noreen, M. Atif. Prevalence of Hepatitis B and Hepatitis C Infection among Patients Undergoing Dialysis. Journal of Human Virology and Retrovirology; 3 (3).
Browse journals by subject